Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting ; volume:23 ; number:1 ; day:8 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
BMC cancer ; 23, Heft 1 (8.8.2023), 1-12, 12.2023
- Creator
-
Putri, Septiara
Saldi, Siti Rizny F.
Khoe, Levina Chandra
Setiawan, Ery
Megraini, Amila
Santatiwongchai, Benjarin
Nugraha, Ryan R.
Permanasari, Vetty Y.
Nadjib, Mardiati
Sastroasmoro, Sudigdo
Armansyah, Armansyah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-11253-y
- URN
-
urn:nbn:de:101:1-2023110208410747437104
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Putri, Septiara
- Saldi, Siti Rizny F.
- Khoe, Levina Chandra
- Setiawan, Ery
- Megraini, Amila
- Santatiwongchai, Benjarin
- Nugraha, Ryan R.
- Permanasari, Vetty Y.
- Nadjib, Mardiati
- Sastroasmoro, Sudigdo
- Armansyah, Armansyah
- SpringerLink (Online service)
Other Objects (12)
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
CrcZ
Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
First-line antibiotic susceptibility pattern of toxigenic Corynebacterium diphtheriae in Indonesia
CRC (Cyclic Redundancy Check)
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Children's Resource Centre, Kapstadt (CRC)
Report: Cultural Research Centre (CRC)
Fast and Flexible CRC Calculation
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
CrcZ
Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
First-line antibiotic susceptibility pattern of toxigenic Corynebacterium diphtheriae in Indonesia
CRC (Cyclic Redundancy Check)
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Children's Resource Centre, Kapstadt (CRC)
Report: Cultural Research Centre (CRC)
Fast and Flexible CRC Calculation
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
CrcZ
Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
First-line antibiotic susceptibility pattern of toxigenic Corynebacterium diphtheriae in Indonesia
CRC (Cyclic Redundancy Check)
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Children's Resource Centre, Kapstadt (CRC)
Report: Cultural Research Centre (CRC)
Fast and Flexible CRC Calculation
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis